Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/15/24 16:05 | 11/13/24 | VERA | Health | Drug | Pharmaceutical Preparations | Fordyce Marshall | CA | DO | P,CEO | 9 | S.d | -6,913 | 40.67 | 0 | -170 | 337 | D | |||||||||||||||
10/30/24 16:06 | 10/28/24 | VERA | Health | Drug | Pharmaceutical Preparations | Seidenberg Beth C | CA | D | 2 | S.m | -1,417 | 45.01 | 0 | -31 | 151 | D | ||||||||||||||||
5/17/24 16:21 | 5/15/24 | VERA | Health | Drug | Pharmaceutical Preparations | Young Joseph R | CA | O | SVP,Fina | 2 | S.dm | -1,533 | 41.94 | 0 | -37 | 53 | D | |||||||||||||||
4/5/24 21:32 | 4/3/24 | VERA | Health | Drug | Pharmaceutical Preparations | Grant Sean | CA | O | CFO | 1 | S.d | -4,690 | 39.58 | 0 | -118 | 71 | M | |||||||||||||||
3/25/24 21:46 | 3/21/24 | VERA | Health | Drug | Pharmaceutical Preparations | Katabi Maha | CA | D | 1 | S.m | -34,100 | 40.86 | 0 | -834 | 2,794 | I | ||||||||||||||||
1/12/24 21:55 | 1/10/24 | VERA | Health | Drug | Pharmaceutical Preparations | Commodore Capital LP | NY | T | 1 | S | -18,900 | 18.00 | 0 | -1,050 | 4,400 | I | ||||||||||||||||
8/23/23 17:59 | 8/21/23 | VERA | Health | Drug | Pharmaceutical Preparations | Lin Celia | CA | O | Chief Me | 1 | S | -25 | 16.66 | 0 | -1 | 11 | D | |||||||||||||||
8/23/23 17:57 | 8/21/23 | VERA | Health | Drug | Pharmaceutical Preparations | Curley Joanne | CA | O | Chief De | 1 | S | -25 | 16.66 | 0 | -1 | 27 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |